03:30 PM EDT, 06/16/2025 (MT Newswires) -- Health care stocks declined late Monday afternoon, with the NYSE Health Care Index shedding 0.9% and the Health Care Select Sector SPDR Fund (XLV) down 0.6%.

The iShares Biotechnology ETF (IBB) eased 0.3%.

In corporate news, AbbVie ( ABBV ) said Monday that a global phase 3 trial assessing venetoclax plus azacitidine to treat newly diagnosed higher-risk myelodysplastic syndrome did not meet the primary endpoint for overall survival. AbbVie ( ABBV ) shares were down 0.4%.